Waters | WAT - Ebitda

Aktienkurs
304.09
Täglich Wechseln
-0.15 -0.05%
Monatlich
-0.52%
Jährlich
-6.66%
Q2 Prognose
295.08




Ebitda Veränderung Datum
Agilent USD 540M 74M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
Bio Techne USD 103.42M 7.47M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Danaher USD 2.13B 252M 2025-12
Dentsply International USD 135M 32M 2025-12
General Electric Aerospace USD 3.04B 185M 2025-09
Hologic USD 330.4M 16.6M 2025-12
Illumina USD 332M 12M 2025-09
Intuitive Surgical USD 919.7M 21M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
Merck USD 8.39B 1.97B 2025-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Quest Diagnostics USD 537M 24M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Veracyte USD 42.31M 2.58M 2025-12
Waters USD 380.97M 85.83M 2025-12